Moolec Science (NASDAQ:MLEC – Get Free Report) is one of 665 publicly-traded companies in the “Holding & other investment offices” industry, but how does it weigh in compared to its peers? We will compare Moolec Science to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.
Profitability
This table compares Moolec Science and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Moolec Science | -129.97% | -93.88% | -33.37% |
Moolec Science Competitors | -17.70% | -42.87% | -0.63% |
Valuation and Earnings
This table compares Moolec Science and its peers top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Moolec Science | $5.63 million | -$7.31 million | -4.23 |
Moolec Science Competitors | $995.69 million | $80.90 million | 72.67 |
Institutional and Insider Ownership
0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 54.4% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 26.1% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of current ratings and price targets for Moolec Science and its peers, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Moolec Science | 0 | 0 | 1 | 0 | 3.00 |
Moolec Science Competitors | 128 | 728 | 960 | 19 | 2.47 |
Moolec Science currently has a consensus price target of $6.00, indicating a potential upside of 609.14%. As a group, “Holding & other investment offices” companies have a potential upside of 53.54%. Given Moolec Science’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Moolec Science is more favorable than its peers.
Risk and Volatility
Moolec Science has a beta of -0.54, suggesting that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s peers have a beta of 0.03, suggesting that their average share price is 97% less volatile than the S&P 500.
Summary
Moolec Science peers beat Moolec Science on 10 of the 13 factors compared.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.